Arginase: shedding light on the mechanisms and opportunities in cardiovascular diseases

Z Li, L Wang, Y Ren, Y Huang, W Liu, Z Lv, L Qian… - Cell Death …, 2022 - nature.com
Arginase, a binuclear manganese metalloenzyme in the urea, catalyzes the hydrolysis of L-
arginine to urea and L-ornithine. Both isoforms, arginase 1 and arginase 2 perform …

Role of oxidative stress in calcific aortic valve disease and its therapeutic implications

HZE Greenberg, G Zhao, AM Shah… - Cardiovascular …, 2022 - academic.oup.com
Calcific aortic valve disease (CAVD) is the end result of active cellular processes that lead to
the progressive fibrosis and calcification of aortic valve leaflets. In western populations …

[HTML][HTML] Xanthine oxidoreductase: A leading actor in cardiovascular disease drama

L Polito, M Bortolotti, MG Battelli, A Bolognesi - Redox Biology, 2021 - Elsevier
Cardiovascular diseases (CVD) are the leading cause of global mortality and their
pathogenesis lies mainly in the atherosclerotic process. There are close connections linking …

Current evidence and future perspectives on pharmacological treatment of calcific aortic valve stenosis

M Donato, N Ferri, MG Lupo, E Faggin… - International journal of …, 2020 - mdpi.com
Calcific aortic valve stenosis (CAVS), the most common heart valve disease, is characterized
by the slow progressive fibro-calcific remodeling of the valve leaflets, leading to progressive …

[HTML][HTML] Beyond VICs: Shedding light on the overlooked VECs in calcific aortic valve disease

L Fan, D Yao, Z Fan, T Zhang, Q Shen, F Tong… - Biomedicine & …, 2024 - Elsevier
Calcific aortic valve disease (CAVD) is prevalent in developed nations and has emerged as
a pressing global public health concern due to population aging. The precise etiology of this …

[HTML][HTML] The mechanistic pathways of oxidative stress in aortic stenosis and clinical implications

K Phua, NW Chew, WK Kong, RS Tan, L Ye… - Theranostics, 2022 - ncbi.nlm.nih.gov
Despite the elucidation of the pathways behind the development of aortic stenosis (AS),
there remains no effective medical treatment to slow or reverse its progress. Instead, the …

Models and Techniques to Study Aortic Valve Calcification in Vitro, ex Vivo and in Vivo. An Overview

M Bogdanova, A Zabirnyk, A Malashicheva… - Frontiers in …, 2022 - frontiersin.org
Aortic valve stenosis secondary to aortic valve calcification is the most common valve
disease in the Western world. Calcification is a result of pathological proliferation and …

Aortic valve stenosis and mitochondrial dysfunctions: clinical and molecular perspectives

G Pedriali, G Morciano, S Patergnani… - International Journal of …, 2020 - mdpi.com
Calcific aortic stenosis is a disorder that impacts the physiology of heart valves. Fibrocalcific
events progress in conjunction with thickening of the valve leaflets. Over the years, these …

Metformin alleviates the calcification of aortic valve interstitial cells through activating the PI3K/AKT pathway in an AMPK dependent way

Q En, H Zeping, W Yuetang, W Xu, W Wei - Molecular Medicine, 2021 - Springer
Background Calcific aortic valve disease (CAVD) is the most prevalent valvular disease
worldwide. However, no effective treatment could delay or prevent the progression of the …

[HTML][HTML] A multi-omics view of the complex mechanism of vascular calcification

Y Qian, L Li, Z Sun, J Liu, W Yuan, Z Wang - Biomedicine & …, 2021 - Elsevier
Vascular calcification is a high incidence and high risk disease with increasing morbidity
and high mortality, which is considered the consequence of smooth muscle cell …